EGR1 and ovarian cancer: Up-regulation of both EGR1 and miR-152 inhibit the downstream target genes of miR-152, and ATG14, thus suppressing cisplatin resistance in ovarian cancer cells by preventing protective autophagy in ovarian cancer cells [44].